BiotechTube
Home/QuantX Biosciences/Gregory Bell, M.D.
GB

Gregory Bell, M.D.

Chief Medical Officer

QuantX Biosciences

Therapeutic Areas

ImmunologyInflammation

QuantX Biosciences Pipeline

DrugIndicationPhase
STAT6 inhibitorImmunology/Inflammatory diseasesPreclinical
IL-17 inhibitorImmunology/Inflammatory diseasesPreclinical

Leadership Team at QuantX Biosciences

WL
Wei Li, Ph.D.
Interim Chief Executive Officer
WT
Wayne Tang, Ph.D.
Co-founder, Chief Scientific Officer
YS
Yax Sun, Ph.D.
Co-founder, Chief Technology Officer
View full QuantX Biosciences profile